Biochemical correlates of symptom severity in patients with cholestatic liver disease.

被引：0
|
作者：
Kim, WR [1 ]
Hermans, JE [1 ]
Jorgensen, RA [1 ]
Dickson, ER [1 ]
Lindor, KD [1 ]
机构：
[1] MAYO CLIN & MAYO FDN, ROCHESTER, MN 55905 USA
来源：
GASTROENTEROLOGY | 1997年 / 112卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：A1302 / A1302
页数：1
相关论文
共 50 条
  • [31] QTC DURATION CORRELATES WITH SYMPTOM SEVERITY IN LONG QT SYNDROME PATIENTS
    TIMOTHY, K
    FOX, J
    VINCENT, GM
    CIRCULATION, 1992, 86 (04) : 391 - 391
  • [32] ARTERIAL STIFFNESS CORRELATES WITH THE SEVERITY OF HEPATIC FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Boutari, Chrysoula
    Tziomalos, Konstantinos
    Lefkos, Petros
    Doumas, Michael
    Athyros, Vasilios
    Karagiannis, Asterios
    ATHEROSCLEROSIS, 2017, 263 : E197 - E197
  • [33] In cirrhotic patients variceal bleeding is more frequent in the evening and correlates with severity of liver disease
    Mann, NS
    Hillis, A
    Mann, SK
    Buerk, CA
    Prasad, VM
    HEPATO-GASTROENTEROLOGY, 1999, 46 (25) : 391 - 394
  • [34] Protein depletion and physiologic deficit correlate with severity of liver disease.
    Barclay, KL
    Plank, LD
    Metzger, DJ
    Brokenshire, EM
    Munn, SR
    Gane, EJ
    Hill, GL
    HEPATOLOGY, 1999, 30 (04) : 438A - 438A
  • [35] Development of a disease severity scoring system for patients with Pompe disease.
    Giannini, E. H.
    Berger, K.
    van der Ploeg, A.
    Case, L.
    Dandrea, C.
    Kishnani, P.
    Marsden, D.
    MOLECULAR GENETICS AND METABOLISM, 2008, 93 (03) : 250 - 250
  • [36] INFLUENCE OF URSODEOXYCHOLIC ACID (UDCA) ON BIOCHEMICAL PARAMETERS IN CHOLESTATIC LIVER-DISEASE
    FISHER, MM
    PARADINE, ME
    GASTROENTEROLOGY, 1986, 90 (05) : 1725 - 1725
  • [37] Liver Injury in Patients With Cholestatic Liver Disease Treated With Obeticholic Acid
    Eaton, John E.
    Vuppalanchi, Raj
    Reddy, Rajender
    Sathapathy, Sanjaya
    Ali, Bilal
    Kamath, Patrick S.
    HEPATOLOGY, 2020, 71 (04) : 1511 - 1514
  • [38] The optimal timing of liver transplantation in patients with chronic cholestatic liver disease
    de Rave, S
    Schalm, SW
    TRANSPLANT INTERNATIONAL, 2005, 18 (08) : 937 - 940
  • [39] Transient sulfite oxidase deficiency and S-sulfocysteinuria due to cholestatic liver disease.
    Sparks, SE
    Brooks, BP
    Isaacs, JS
    Higgs, J
    Bloom, MD
    Rosenbaum, KN
    Berry, GT
    MOLECULAR GENETICS AND METABOLISM, 2004, 81 (03) : 180 - 180
  • [40] Changes in the distribution of hepatocellular transporters in human end-stage cholestatic liver disease.
    Milkiewicz, P
    Elias, E
    Williams, A
    Milkiewicz, M
    Keogh, A
    Hubscher, SG
    HEPATOLOGY, 2001, 34 (04) : 470A - 470A
12345